top of page

Why Oral Fluid?


Oral fluid provides a “blood-equivalent” result as it measures molecules similar to those found in blood plasma and its concentration correlates  much closer than urine.

Oral fluid collection is less invasive, easy and quick and happens in front of you.  Since bathrooms are not needed, there is no need to turn off running water, put blue dye in toilets, or perform temperature checks on specimens as is the case with urine testing.


 Oral fluid testing, in general, is very cost-effective when compared to other drug testing methods. 


3rd Party collection costs can be eliminated entirely. 

20230426 Drug Window of Detection.jpg

Watch our instructional video on how to use the mLife Verify device.

Visual Interpretation of mLife Verify Results


• Two lines appear. One line visible in the control region (C), and another line visible in the test region (T).
• This indicates the drug concentration is below the detectable level.

• One line appears in the control region (C). No line appears in the test region (T).
• The lack of a line in the test region (T) indicates a presumptive positive result for the corresponding drug of that specific test region.

• Control line fails to appear.
• Insufficient specimen volume or incorrect procedural techniques are the most likely reason for control line failure.  

Interpretation of Results_mLife_Oral Sal
Annotation 2020-04-24 170249.jpg

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

Efforts to control SARS-CoV-2, the novel coronavirus causing COVID-19 pandemic, dependon accurate and rapid diagnostic testing. These tests must be ( 1 ) sensitive to mild andasymptomatic infections to promote effective self isolation and reduce transmission withinhigh risk groups 1; ( 2 ) consistent to reliably monitor disease progression and aid clinicaldecisions 2; and ( 3 ) scalable to inform local and national public health policies, such as when
social distancing measures can be safely relaxed.

Annotation 2020-04-24 170759.jpg

Consistent Detection of 2019 Novel
Coronavirus in Saliva

The 2019 novel coronavirus (2019-nCoV) was detected in the
self-collected saliva of 91.7% (11/12) of patients. Serial saliva
viral load monitoring generally showed a declining trend. Live
virus was detected in saliva by viral culture. Saliva is a promising
noninvasive specimen for diagnosis, monitoring, and infection
control in patients with 2019-nCoV infection.


Drug use and abuse are critical social issues in the United States in 2018. Two drug families in particular stand out: marijuana (cannabinoids) and opioids.

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs

bottom of page